North & Central America

This archive covers progress stories from North and Central America, spanning the U.S., Canada, Mexico, and the nations of Central America. Readers will find reporting on health, environment, community resilience, and policy advances across the region.

Dried psilocybin mushrooms on a surface for an article about psilocybin therapy legalization in New Mexico, for article on Oregon psilocybin facilitators

New Mexico becomes the third U.S. state to legalize psilocybin therapy

By / / Good News For Humankind

New Mexico’s Medical Psilocybin Act makes the state the third in the U.S. to legalize psilocybin therapy, but its path stands apart from Oregon and Colorado. Rather than a ballot measure, the legislation passed through the state legislature with an overwhelming bipartisan margin of 56 to 8 in the House. The law creates a regulated clinical framework for treating PTSD, treatment-resistant depression, and other conditions, with a dedicated 30,000 equity fund to subsidize access for low-income patients. That combination of legislative flexibility and built-in affordability measures offers a replicable model for other states watching closely.

Solar panels and wind turbines generating power on open land for an article about U.S. clean electricity

Fossil fuels fall below half of U.S. electricity for the first time on record

By / / Good News For Humankind

U.S. clean electricity reached a historic milestone in April 2025, when fossil fuels dropped below 50% of American electricity generation for the first time since the coal-powered grid emerged in the 1800s. According to energy research firm Ember, coal, oil, and natural gas fell to roughly 47% of total generation, with wind, solar, hydro, and nuclear powering the rest. This shift was driven by a 90% drop in wind and solar costs since 2010, triggering sustained investment now visible in real grid output. The milestone matters because it breaks the long-held assumption that fossil fuels are the inevitable backbone of modern electricity.

Chevron gas station located near a Louisiana wetlands restoration project site along the coast, for article on Louisiana wetlands restoration

Chevron ordered to pay $740 million to restore Louisiana coast in landmark trial

By / / Good News For Humankind

Louisiana wetlands just got a powerful new defender: a jury ordered Chevron to pay $744.6 million to restore marshland in Plaquemines Parish, with interest pushing the total past $1.1 billion. Jurors found that Texaco, which Chevron acquired in 2001, had spent decades dredging canals and dumping wastewater into the marsh without meaningful cleanup. The ruling matters far beyond one rural parish — it’s the first of dozens of similar cases to reach trial, and the communities on this vanishing coast are disproportionately Black, Indigenous, and low-income. As courts from Europe to the Americas increasingly hold polluters accountable, this verdict signals that coastal destruction is no longer just a political fight. It’s a legal one.

Prairie Land Potawatomi Nation's Chief Shab-eh-nay, for article on Land Back Illinois

Illinois returns stolen land to Prairie Band Potawatomi Nation

By / / Good News For Humankind

Land Back just scored a major win in Illinois: Governor JB Pritzker signed a law transferring 1,500 acres of Shabbona Lake State Recreation Area to the Prairie Band Potawatomi Nation, honoring a treaty signed in 1829. The land was taken while Chief Shab-eh-nay was visiting family in Kansas, then sold off to settlers. Returning it took years of patient relationship-building by nation chairman Joseph “Zeke” Rupnick, who met repeatedly with neighbors and lawmakers. The park stays open to its half-million annual visitors, with campsites and trails intact — what changes is who holds the title. It’s one parcel, but it’s a real, legally binding step in a movement reshaping how the U.S. reckons with Indigenous land.

A medical professional preparing an injectable syringe for an article about lenacapavir HIV prevention, for article on annual HIV injection

Annual jab for HIV protection passes trial hurdle

By / / Good News For Humankind

A once-yearly HIV prevention shot has just cleared its first safety trial, with the drug lenacapavir still detectable in participants’ bodies a full 56 weeks after a single injection. That’s a hopeful sign for people who find daily prevention pills hard to maintain — whether because of stigma, unstable housing, or simply the grind of remembering. Earlier trials of twice-yearly lenacapavir already showed striking results, and researchers are now testing whether one shot a year could work just as well. With nearly 40 million people living with HIV globally, a prevention tool this simple could reshape what protection looks like — especially for communities where daily medication has never been realistic.

Monarch butterfly, for article on monarch butterfly population, for article on monarch butterfly population

Eastern monarch butterfly population nearly doubles in 2025

By / / Good News For Humankind

Monarch butterflies are bouncing back: this past winter, the eastern population blanketed 4.42 acres of Mexican highland forest, nearly double the area recorded a year earlier. Scientists credit milder drought along the migration route, but they also point to the people doing the quiet, daily work — Indigenous and rural communities in the Monarch Butterfly Biosphere Reserve who patrol against illegal logging, monitor habitat, and run ecotourism that ties their livelihoods to the butterflies’ return. It’s a fragile gain, not a finish line, since the long-term average remains much higher. Still, this rebound is a reminder that cross-border conservation can work — and that protecting a 3,000-mile migration takes all of us, everywhere along the way.

Two people holding hands, for article on Parkinson's infusion device, for article on Onapgo approval

U.S. approves “milestone” Parkinson’s treatment for 2025 release

By / / Good News For Humankind

Onapgo, a new wearable approved by the FDA, will give Americans with Parkinson’s a continuous, non-surgical way to manage their symptoms when it launches in late 2025. The small device delivers a steady infusion of apomorphine under the skin, bypassing the digestive system entirely — a real advantage for a disease that often slows digestion and makes pills unpredictable. In trials, patients cut their daily “off” episodes — those rough stretches when medication wears off and tremors return — by nearly two and a half hours on average. The therapy has quietly helped European patients for about three decades, and its U.S. arrival opens a gentler path for the roughly one million Americans living with Parkinson’s, part of a growing global push toward more humane, individualized care.

A doctor reviewing a prescription pad in a clinical setting for an article about non-opioid pain drug approval

FDA approves first non-opioid pain drug in more than 20 years

By / / Good News For Humankind

The FDA’s approval of Journavx (suzetrigine), a first-in-class non-opioid pain drug, marks the most significant shift in acute pain treatment in over two decades. Developed by Vertex Pharmaceuticals, the drug blocks a specific sodium channel in the peripheral nervous system, stopping pain signals before they reach the brain without engaging the opioid pathways linked to addiction and overdose. Two rigorous clinical trials confirmed its effectiveness for moderate to severe acute pain. With more than 500,000 opioid overdose deaths in the U.S. since 1999, this approval offers patients and doctors a genuinely new choice — one that treats real pain without the shadow of dependence.

A heat pump unit on a home exterior, representing U.S. heat pump sales growth supported by the Kigali Amendment, for article on heat pump agreement

Heat pumps outsell gas furnaces in the U.S. for the second year running

By / / Good News For Humankind

Heat pump sales have now surpassed gas furnace shipments in the United States for two consecutive years, with more than 4 million units sold in 2023 alone — a milestone that is beginning to look like a permanent market shift. Driven by federal tax credits under the Inflation Reduction Act and additional state-level rebates, Americans are increasingly choosing electric heating over fossil fuels. This matters because home heating accounts for roughly 10% of U.S. greenhouse gas emissions, and unlike gas furnaces, heat pumps grow cleaner automatically as the electrical grid adds more renewable energy. The two-year streak signals that economics, policy, and technology have aligned in ways that rarely reverse.

Karla Sofia Gascón at 2024 Cannes Film Festival, for article on trans actor Oscar nomination

Karla Sofía Gascón just became the first out trans actor to score an Oscar nomination

By / / Good News For Humankind

Karla Sofía Gascón just became the first openly transgender person ever nominated for an acting Oscar, earning a best actress nod for her leading role in Emilia Pérez. The French-Spanish musical swept up 13 nominations in total, falling just one shy of the all-time record. Gascón, who transitioned in 2018, plays a cartel boss building a new life after her own transition — a role she fought for and says she could only have brought this depth to later in life. Her nomination won’t fix Hollywood’s long gap in trans representation overnight, but it cracks open a door that was firmly shut, signaling to studios and audiences alike that trans stories told with authenticity belong at the center of the screen.